934 results on '"Geissler, Edward K."'
Search Results
2. Proteolytic shedding of CD46 from human hepatocytes indicates liver stress
3. Hepatitis E virus infection in immunosuppressed patients and its clinical manifestations
4. Immune profile of patients with peritoneal carcinomatosis selected for CRS-HIPEC therapy
5. Soluble CD46 as a diagnostic marker of hepatic steatosis
6. Donor antigen-specific regulatory T cell administration to recipients of live donor kidneys: A ONE Study consortium pilot trial
7. Regulatory cell therapy in kidney transplantation (The ONE Study): a harmonised design and analysis of seven non-randomised, single-arm, phase 1/2A trials.
8. A Phase I/IIa study of autologous tolerogenic dendritic cells immunotherapy in kidney transplant recipients
9. A non-canonical vitamin K cycle is a potent ferroptosis suppressor
10. Validation of the R3-AFP model for risk prediction of HCC recurrence after liver transplantation in the SiLVER randomized clinical trial.
11. Establishing Guidelines for Organ Donation Systems
12. Cytokine Response of Natural Killer Cells to Hepatitis B Virus Infection Depends on Monocyte Co-Stimulation
13. Incidence and Mortality of Malignant Melanoma in Relation to Dermatologist Density in Bavaria
14. Pressure distribution and flow characteristics during negative pressure wound therapy
15. Good outcomes after repeated pediatric liver retransplantations: A justified procedure even in times of organ shortage
16. Virus-specific memory T cell responses unmasked by immune checkpoint blockade cause hepatitis
17. Successful auxiliary two-staged partial resection liver transplantation (ASPIRE-LTx) for end-stage liver disease to avoid small-for-size situations
18. Human Tolerogenic Dendritic Cells Regulate Immune Responses through Lactate Synthesis
19. Oxygen levels during negative pressure wound therapy
20. The effector program of human CD8 T cells supports tissue remodeling
21. Ribavirin Improves NK Cell IFNγ Response During Sofosbuvir-based DAA Therapy in HCV-infected Liver Transplant Recipients
22. Inhibition of mTORC2/RICTOR Impairs Melanoma Hepatic Metastasis
23. Ribavirin Improves NK Cell IFNγ Response During Sofosbuvir-based DAA Therapy in CV-infected Liver Transplant Recipients
24. Case report: Predictability of clinical response and rejection risk after immune checkpoint inhibition in liver transplantation
25. Novel GM-CSF signals via IFN-γR/IRF-1 and AKT/mTOR license monocytes for suppressor function
26. Negative pressure wound therapy (NPWT) on closed incisions to prevent surgical site infection in high-risk patients in hepatopancreatobiliary surgery: study protocol for a randomized controlled trial—the NP-SSI trial
27. Contributors
28. mTOR Inhibition Is Most Beneficial After Liver Transplantation for Hepatocellular Carcinoma in Patients With Active Tumors
29. Transplantation Direct: TTS eJournal Progress Update
30. Randomized Sirolimus-based Early Calcineurin Inhibitor Reduction in Liver Transplantation: Impact on Renal Function
31. LDHA-Associated Lactic Acid Production Blunts Tumor Immunosurveillance by T and NK Cells
32. IRAK-M Expression in Tumor Cells Supports Colorectal Cancer Progression through Reduction of Antimicrobial Defense and Stabilization of STAT3
33. RORγt+ IL-22-producing NKp46+ cells protect from hepatic ischemia reperfusion injury in mice
34. Anti-BAFF Treatment Interferes With Humoral Responses in a Model of Renal Transplantation in Rats
35. Approaches to the Induction of Tolerance
36. Can Mycophenolic Acid-based Immunosuppression Benefit Liver Transplant Patients With HCC?
37. Data from Dietary Immunosuppressants Do Not Enhance UV-Induced Skin Carcinogenesis, and Reveal Discordance between p53-Mutant Early Clones and Carcinomas
38. Supplementary Table 1, Figures 1 - 4 from Dietary Immunosuppressants Do Not Enhance UV-Induced Skin Carcinogenesis, and Reveal Discordance between p53-Mutant Early Clones and Carcinomas
39. Supplementary Data from Up-Regulation of Krüppel-Like Factor 5 in Pancreatic Cancer Is Promoted by Interleukin-1β Signaling and Hypoxia-Inducible Factor-1α
40. Data from Up-Regulation of Krüppel-Like Factor 5 in Pancreatic Cancer Is Promoted by Interleukin-1β Signaling and Hypoxia-Inducible Factor-1α
41. Supplementary Figure 1 from Extracellular Citrate Affects Critical Elements of Cancer Cell Metabolism and Supports Cancer Development In Vivo
42. Data from Extracellular Citrate Affects Critical Elements of Cancer Cell Metabolism and Supports Cancer Development In Vivo
43. Supplementary Figure S6 from Extracellular Citrate Affects Critical Elements of Cancer Cell Metabolism and Supports Cancer Development In Vivo
44. Supplementary Table S1 from Extracellular Citrate Affects Critical Elements of Cancer Cell Metabolism and Supports Cancer Development In Vivo
45. Supplementary Fig. S1 from Dual targeting of Raf and VEGF receptor 2 reduces growth and metastasis of pancreatic cancer through direct effects on tumor cells, endothelial cells, and pericytes
46. A Phase I/IIa study of autologous tolerogenic dendritic cells immunotherapy in kidney transplant recipients
47. Now or never? The case for cell-based immunosuppression in kidney transplantation
48. Early γGT and bilirubin levels as biomarkers for regeneration and outcomes in damaged bile ducts after liver transplantation
49. Immunomodulation of Natural Killer Cell Function by Ribavirin Involves TYK-2 Activation and Subsequent Increased IFN-γ Secretion in the Context of In Vitro Hepatitis E Virus Infection
50. Immunomodulation of Natural Killer Cell Function by Ribavirin Involves TYK-2 Activation and Subsequent Increased IFN-γ Secretion in the Context of In Vitro Hepatitis E Virus Infection
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.